The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture

Virus Research

Volumn 69, Issue 1, 2000, Pages 31-39

  Holbrook, Michael R ^a   Li, Li ^a   Suderman, Miguel T ^a   Wang, Heiman ^a   Barrett, Alan D T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Attenuation; Flavivirus; FNV; Yellow fever

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; GENE DELETION; MOUSE; NEUROPATHOLOGY; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VERO CELL; VIRUS CULTURE; VIRUS MUTATION; VIRUS PURIFICATION; VIRUS STRAIN; VIRUS VIRULENCE; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; DNA, VIRAL; GENES, VIRAL; MICE; MUTATION; NERVOUS SYSTEM DISEASES; VERO CELLS; VIRULENCE; VIRUS CULTIVATION; YELLOW FEVER; YELLOW FEVER VACCINE; YELLOW FEVER VIRUS;

ANIMALIA; FLAVIVIRUS; RNA VIRUSES; YELLOW FEVER VIRUS;

EID: 0034632645     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00168-4     Document Type: Article

References (14)

1. Barrett A.D.T., Gould E.A. Comparison of neurovirulence of different strains of yellow fever virus in mice. J. Gen. Virol. 67:1986;631-637.
2. Barrett A.D.T. Yellow fever vaccines. Bull. Inst. Pasteur. 85:1987;103-124.
3. Fulop L.D., Barrett A.D.T., Titball R.W. Nucleotide sequence of the NS5 gene of Banzi virus: comparison with other flaviviruses. J. Gen. Virol. 76:1995;2317-2321.
4. Koonin E.V. The phylogeny of RNA-dependent RNA polymerases of positive-strand RNA viruses. J. Gen. Virol. 72:1991;2197-2206.
5. Pisano M.R., Mercier V., Deubel V., Tolou H. Complete nucleotide sequence and phylogeny of an American strain of yellow fever virus TRINID79A. Arch. Virol. 144:1999;1837-1843.
6. Proutski V., Gritsum T.S., Gould E.A., Holmes E.C. Biological consequences of deletions within the 3′-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res. 64:1999;107-123.
7. Rey F.A., Heinz F.X., Mandl C.W., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis at 2 Å resolution. Nature. 375:1995;291-298.
8. Rice C.M., Lenches E.M., Eddy S.R., Shih S.J., Sheets R.L., Strauss J.H. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science. 229:1985;726-733.
9. Ryman K.D., Xie H., Ledger T.N., Campbell G.A., Barrett A.D.T. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice. Virology. 230:1997;376-380.
10. Ryman K.D., Ledger T.N., Campbell G.A., Watowich S.J., Barrett A.D.T. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology. 244:1998;59-65.
11. Wang E., Ryman K.D., Jennings A.D., et al. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever with its vaccine derivative French neurotropic vaccine. J. Gen. Virol. 76:1995;2749-2755.
12. Wang E., Weaver S.C., Shope R.E., Tesh R.B., Watts D.M., Barrett A.D.T. Genetic variation in yellow fever virus: duplication in the 3′ noncoding region of strains from Africa. Virology. 225:1996;274-281.
13. Xie H., Ryman K.D., Gampbell G.A., Barrett A.D.T. Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus. J. Gen. Virol. 79:1998;1895-1899.
14. Xie H., Cass A.R., Barrett A.D.T. Yellow fever 17D vaccine virus isolated from healthy vaccines accumulates very few mutations. Virus Res. 55:1998;93-99.